-
Why Is the Rate of Uterine Cancer Rising?
Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.
by Ashley P. Taylor
-
Starting a Conversation
Palliative care physician Dawn Gross helps people talk about death by focusing on what they want during life.
by Amy Paturel
-
Helping Cancer Survivors Sleep
A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.
by Cheryl Platzman Weinstock
-
Cancer Care on a Native American Reservation
For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.
by Kate Yandell
-
Walking Back From Cancer
An American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.
by Steven Ford
-
Proton Therapy Is Associated With Reduced Side Effects
When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.
by Sue Rochman
-
So You Want to Serve on a Scientific Review Panel?
Cancer patient advocates who review research proposals can provide valuable perspective.
by Bob Riter, Monica Vakiner and Carole Baas
-
When a Top-Ranked Cancer Center Comes to a Hospital Near You
Research shows prominent cancer hospitals have different surgical outcomes than their affiliates.
by Marci A. Landsmann
-
Putting Chemotherapy Side Effects on Ice
A small study shows that keeping ice chips in the mouth during oxaliplatin chemotherapy may prevent cold sensitivity, a common oral side effect.
by Anna Azvolinsky
-
Coping With Trauma
Nearly six years after being diagnosed with stage IV colon cancer, disaster psychologist Jamie Aten is still learning new ways of coping with the trauma stemming from his diagnosis and treatment.
by Jamie Aten
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore